摘要 |
FIELD: medicine, urology. SUBSTANCE: method of enuresis treatment involves the use of (S)-oxybutynin, (S)-desethyloxybutynin or their pharmaceutically acceptable salts with content of corresponding (R)-enantiomer 10 wt. %, not above. Invention allows to prevent adverse effects of treatment with racemic oxybutynin and desethyloxybutynin. EFFECT: enhanced effectiveness of treatment. 10 cl, 12 tbl |